Indian shares set to open flat as US election results trickle in
Nov 6 (Reuters) -Indian shares are set to open flat on Wednesday, with caution likely to prevail as U.S. presidential election results trickle in.
The Gift Nifty futures GIFc1 were trading at 24,268, as of 07:48 a.m. IST, indicating that the benchmark Nifty 50 .NSEI will open near Tuesday's close of 24,213.3.
Other Asian markets traded lower, with the MSCI Asia ex-Japan index .MIAPJ0000PUS shedding 0.4%, as early results from the U.S. presidential election suggested the race remained too close to call.
Republican Donald Trump won eight states while Democrat Kamala Harris captured three states and Washington, D.C., Edison Research projected, but critical battleground states were unlikely to be called for hours or even days.
A Trump win could lead to lower corporate tax rates in the United States, and is expected to boost spending and benefit several equity sectors in India, according to analysts.
A Harris victory, meanwhile, is seen as a sign of policy continuity, a neutral-to-mildly-positive outcome for Indian stocks, they said.
"Clarity on the outcome of U.S. election will influence markets trajectory in this session," said Deepak Jasani, head of retail research, HDFC Securities.
Indian shares recouped losses to log gains on Tuesday, led by banks, as investors sought safety in segments with cheaper valuations.
The market's recovery in the previous session was driven by short-covering ahead of the U.S. results, but caution persists amid weak earnings and lackluster quarterly results.
Foreign institutional investors sold domestic equities for the 27th consecutive session, offloading stocks worth 25.69 billion Indian rupees, on a net basis.
The benchmark Nifty is about 8% below the all-time high hit on Sept. 27, weighed by record monthly foreign outflows in October as investors directed funds to China from India on Beijing's stimulus measures and cheaper valuations.
The moderation in corporate earnings growth for the September quarter has also weighed on the markets.
STOCKS TO WATCH
** Drugmaker Dr Reddy's Laboratories REDY.NS misses September-quarter profit view on weak U.S. demand
** Mankind Pharma MNKI.NS tops second-quarter profit view on higher demand for chronic drugs
** Titan TITN.NS sees drop in second-quarter profit as gold import tax cut drives inventory losses
** Initial public offering of Swiggy SWIG.NS will open for subscription from Wednesday until Nov. 8, and the stock is expected to list on domestic bourses on Nov. 13
Reporting by Bharath Rajeswaran in Bengaluru; Editing by Sherry Jacob-Phillips
Berita Terkini
Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.
Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.
Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.
